We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PSURs on APIs in Nationally Authorized Medicines Only Now Subject to EMA Centralized Assessment
PSURs on APIs in Nationally Authorized Medicines Only Now Subject to EMA Centralized Assessment
Starting this month, active substances found only in medicines authorized at the country level in the EU are subject to centralized review of period safety update reports by the European Medicines Agency.